C4 Therapeutics, Inc. · NASDAQ:CCCC

Anderson Kenneth Carl exercised options for 1,070 C4 Therapeutics, Inc. shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 4, 2026

On Jun 1, 2026, Anderson Kenneth Carl (Director) exercised options for 1,070 C4 Therapeutics, Inc. shares at US$2.11 for US$2,258, leaving 69,300 shares. Filed Jun 4, 2026 (Form 4).

Options exercised
1,070 shares
Price
US$2.11
Value
US$2,258
Holding after
69,300 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common StockOption exercise1,070US$2.1169,300Direct

Source

View original at SEC

Related